Scanadu cofounder Sam De Brouwer demonstrates the Scout and Scanaflo
At CES this week I met with a very interesting company called Scanadu which makes two interesting healthcare products that connect with the iPhone…
The Scanadu Scout (pictured, right) is a little electronic device designed by Yves Béhar that you touch to your forehead for a few seconds. Almost instantly, physiological parameters, including temperature, heart rate, blood oxygenation, respiratory rate, ECG, and diastolic/systolic blood pressure are sent to an app on your iPhone which logs these measurements and alerts users to anomalies and deviations which may be cause for heath concerns.
The Scout closed a $1.6M Indigogo funding round in 2013 and is still trying to push the product through the FDA as it tries to get deliveries to customers.
Perhaps more interesting however, Scnadu introduced its new “Scanaflo” device at CES 2015 which is a home urinalysis apparatus that uses your iPhone’s camera to image a set of colors strips.
The strips are all dipped in the patient’s urine and change color based on the levels of important chemicals found within. The various colors indicate the levels of glucose, protein, leukocytes, nitrites, blood, bilirubin, urobilinogen, microalbumin, creatinine, ketone, specific gravity, and pH in urine. Almost instantly after taking the picture, the app has a good idea of the chemical composition of the urine.
Again, the app logs your levels to compare it against a history and alerts to anomalies and potentially harmful deviations.
Interestingly, De Brouwer indicated that the Scanaflo could easily be upgraded to be a drug/urine testing apparatus which would open up a huge can of worms but also enable parents of troubled teens to know that their children were behaving. Obviously there would be privacy concerns.
Scanadu is also trying to push the Scanaflo through the FDA and hopes to have it in customer hands later this year.
9to5Mac’s CES 2015 coverage brought to you by:
FTC: We use income earning auto affiliate links. More.